News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nolato: Strong Earnings and High Return on Capital


7/19/2013 7:11:19 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Regulatory News:

In today’s interim report, Nolato (STO:NOLAB) reports strong earnings and a high return on capital for the second quarter. Sales increased by 11% to SEK 1,164 million (1,046) and operating income (EBITA) increased by 37% to SEK 111 million (81). Earnings per share increased to SEK 2.97 (2.05) and the cash flow after investments amounted to SEK 120 million (56, excluding acquisitions).

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES